RAPTOR Platform & Hypercoding Assays
Multi-omic biomarker detection for oncology and other clinical areas
Key Facts
About Pleno
Pleno is a private, pre-revenue biotech company developing a disruptive genomics platform called Hypercoding, which is designed to detect multi-omic biomarkers (DNA, RNA, methylation, protein) with unprecedented speed, scale, and cost-efficiency. Its core product is the RAPTOR instrument, which combines advanced biochemical probes with signal processing algorithms derived from telecommunications to decode vast amounts of genetic information from a sample. The company aims to democratize clinical genomics by addressing the critical bottlenecks of total cost, turnaround time, and workflow complexity that currently limit market penetration in oncology and other areas. Pleno is positioned as a platform and diagnostics company targeting the vast, untapped market for routine clinical genomic testing.
View full company profile